期刊文献+

辛伐他汀治疗脂肪肝对患者肝功能及睡眠质量的影响 被引量:1

Effects of Simvastatin on Liver Function and Sleep Quality in Patients with Fatty Liver
下载PDF
导出
摘要 目的:观察辛伐他汀治疗脂肪肝对患者肝功能及睡眠质量的影响。方法:选取2016年4月至2018年4月福建医科大学孟超肝胆医院肝内科收治的非酒精性脂肪肝患者60例作为研究对象,随机分为观察组和对照组,每组30例。对照组低脂饮食,适当运动,观察组在对照组的基础上服用辛伐他汀治疗。比较2组患者血脂变化、肝功能变化、睡眠质量变化。结果:2组患者治疗初始血脂各项指标之间无统计学意义(P> 0. 05),治疗后观察组患者的TC、LDL-C、TG均显著低于对照组,HDL-C高于对照组(P <0. 05)。2组患者治疗初始肝功能各项指标之间无统计学意义(P> 0. 05),治疗后观察组患者的ALT、AST、γ-GGT、TBi L均显著低于对照组(P <0. 05)。2组患者在治疗前和治疗后PSQI评分均无统计学意义(P> 0. 05)。结论:辛伐他汀能够有效调节血脂,改善脂肪肝患者肝功能的同时不影响患者睡眠质量。 Objective: To observe the effect of simvastatin on liver function and sleep quality in patients with fatty liver. Methods: A Total of 60 patients with non-alcoholic fatty liver admitted to the Department of Hepatology of our hospital from April 2016 to April 2018were studied as the research objects.They were randomly divided into simvastatin group and control group with 30 patients in each group.The control group was fed a low-fat diet and exercised properly.The simvastatin group was treated with simvastatin on the basis of the control group.The changes of blood lipid, liver function and sleep quality were compared between the two groups. Results: There was no difference in the initial blood lipid indexes between the two groups( P >0.05).After treatment, TC, LDL-C and TG in the simvastatin group were significantly lower than those in the control group, and HDL-C was higher than that in the control group( P <0.05).There was no difference in the initial liver function between the two groups( P >0.05).After treatment, the ALT, AST, gamma-GGT and TBiL in simvastatin group were significantly lower than those in control group( P <0.05).There was no significant difference in PSQI scores between the two groups before and after treatment( P >0.05). Conclusion: Simvastatin can effectively regulate blood lipid and improve liver function in patients with fatty liver without affecting sleep quality.
作者 林秋香 王雪雯 潘晨 黄祖雄 Lin Qiuxiang;Wang Xuewen;Pan Chen;Huang Zuxiong(Department of hepatology, mengchao hepatobiliary hospital, Fujian medical university,Fuzhou 350004,China)
出处 《世界睡眠医学杂志》 2019年第3期278-279,共2页 World Journal of Sleep Medicine
基金 福建省科技厅引导性项目(2017D0002) 福州市科技计划项目(榕科(2016)191号)
关键词 辛伐他汀 脂肪肝 肝功能 睡眠质量 Simvastatin Fatty liver Liver function Sleep quality
  • 相关文献

参考文献3

二级参考文献61

  • 1范建高 曾民德 等.上海市4009名机关职员脂肪肝流行病学调查[J].中华肝脏病杂志,1998,6(1):17-17.
  • 2Targher G, Bertolini L, Padovani R, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients[J]. Diabetes Care, 2007, 30(5): 1212-1218.
  • 3Targher G, Bertolini L, Rodella S, et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proli- ferative/laser-treated retinopathy in type 2 diabetic patients[J]. Diabetologia, 2008, 51(3): 444-450.
  • 4Fracanzani AL, Valenti L, Bugianesi E, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes[J]. Hepatology, 2008, 48(3): 792-798.
  • 5Williamson RM, Price JF, Glancy S, et al. Prevalence of and risk factors for hepatic steatosis and nonalcoholic fatty liver disease in people with type 2 diabetes: the Ed- inburgh type 2 diabetes study[J]. Diabetes Care, 2011, 34(5): 1139-1144.
  • 6Kotronen A, Peltonen M, Hakkarainen A, et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors [J]. Gastroenterology, 2009, 137(3): 865-872.
  • 7Stepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are independent predictors of mortal- ity in patients with chronic liver disease: a population- based study[J]. Gut, 2010, 59(10): 1410-1415.
  • 8Fabbrini E, Magkos F, Mohammed BS, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity[J]. Proc Natl Acad Sei USA, 2009, 106 (36): 15430-15435.
  • 9Nagle CA, An J, Shiota M, et al. Hepatic overexpression of glycerol-sn-3-phosphate acyhransferase 1 in rats caus- es insulin resistance [J]. J Biol Chem, 2007, 282 (20): 14807-14815.
  • 10Neschen S, Morino K, Hammond LE, et al. Prevention of hepatic steatosis and hepatic insulin resistance in mito- chondrial acyl-CoA: glycerol-sn-3-phosphate acyltransferase 1 knockout mice[J]. Cell Metab, 2005, 2(1): 55-65.

共引文献610

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部